Vertex Pharmaceuticals VRTX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's common stock, shares authorized (in shares)?
- Vertex Pharmaceuticals (VRTX) reported common stock, shares authorized (in shares) of 500M in Q1 2026.
- How has Vertex Pharmaceuticals's common stock, shares authorized (in shares) changed year-over-year?
- Vertex Pharmaceuticals's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from 500M to 500M.
- What is the long-term trend for Vertex Pharmaceuticals's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 500M to 500M.